Beta Bionics Inc

Research Beta Bionics Inc (BBNX) on Bullrun: market cap USD 757.55M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBBNX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 757.55M
• Financial periodFY2025
• RevenueUSD 100.25M
• Revenue growth53.9%
• Net income-USD 73.20M
• Free cash flow-USD 56.22M
• Gross margin55.4%

Valuation Snapshot

latest market cap is USD 757.55M.

About Beta Bionics Inc

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.

Frequently asked questions

What is Beta Bionics Inc's market cap?

Beta Bionics Inc's market capitalization is USD 757.55M.

What does Beta Bionics Inc do?

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes.